Successful treatment of refractory low grade duodenal lymphoma with rituximab, an anti-CD20 monoclonal antibody. [electronic resource]
Producer: 20040128Description: 408-10 p. digitalISSN:- 1537-453X
- Adult
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Murine-Derived
- Antigens, CD20
- Antineoplastic Agents -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Duodenal Neoplasms -- drug therapy
- Female
- Humans
- Lymphoma, Non-Hodgkin -- drug therapy
- Rituximab
- Treatment Failure
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.